Stay updated with breaking news from Shareholder Intelligence Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eric Sprott has called for Canada’s short selling regulations to be changed as alleged illegal short selling is having a widespread negative impact on...
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today reported its financial results for the quarter ended June 30, 2023, provided a corporate update and reiterates upcoming milestones.
/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a growing pipeline,...
HOUSTON, Aug. 7, 2023 /PRNewswire/ -- Moleculin Biotech, Inc., , a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today...
Micromobility.com Inc. Strengthens its Commitment to Shareholders Amidst Detected Trading Imbalances ...